Drug: Leronlimab Company: CytoDyn Inc. Website
Post# of 148179
(Total Views: 748)
Posted On: 05/23/2020 9:15:07 PM
Drug: Leronlimab
Company: CytoDyn Inc.
Website: https://www.cytodyn.com/
Clinical Trial Enrollment:
Mild to Moderate: https://www.cytodyn.com/clinical-trial-enrollment
Severe or Critical: https://www.cytodyn.com/clinical-trial-enroll...r-critical
FDA Emergency IND Hotline: 855-543-3784 (Have doctor file with the FDA)
CytoDyn CEO:
Nader Pourhassan, PhD
Director, President & CEO
CytoDyn Inc. (www.cytodyn.com)
1111 Main Street, Suite 660
Vancouver, Washington 98660
(360) 980-8524 Ext. 1
(360) 980-8549 - Fax
(503) 348-4173-Cell
Email: npourhassan@cytodyn.com
Company: CytoDyn Inc.
Website: https://www.cytodyn.com/
Clinical Trial Enrollment:
Mild to Moderate: https://www.cytodyn.com/clinical-trial-enrollment
Severe or Critical: https://www.cytodyn.com/clinical-trial-enroll...r-critical
FDA Emergency IND Hotline: 855-543-3784 (Have doctor file with the FDA)
CytoDyn CEO:
Nader Pourhassan, PhD
Director, President & CEO
CytoDyn Inc. (www.cytodyn.com)
1111 Main Street, Suite 660
Vancouver, Washington 98660
(360) 980-8524 Ext. 1
(360) 980-8549 - Fax
(503) 348-4173-Cell
Email: npourhassan@cytodyn.com
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼